ACT in HCT (Stem Cell Transplant)
What is the Purpose of this Study?
If you choose to join the study, you will:
- Participate in acceptance and commitment therapy (ACT)
- Complete physical function and cognitive function tests
- Fill out questionnaires
- Use an iPhone and Apple Watch to track your activity (these items can be provided)
- Give stool samples
- Have your skin swabbed
- Have blood draws
If your caregiver chooses to join the study, they will:
- Also participate in acceptance and commitment therapy (ACT)
- Fill out questionnaires
- Give stool samples
- Have your skin swabbed
- Have blood draws
- Participate in acceptance and commitment therapy (ACT)
- Complete physical function and cognitive function tests
- Fill out questionnaires
- Use an iPhone and Apple Watch to track your activity (these items can be provided)
- Give stool samples
- Have your skin swabbed
- Have blood draws
If your caregiver chooses to join the study, they will:
- Also participate in acceptance and commitment therapy (ACT)
- Fill out questionnaires
- Give stool samples
- Have your skin swabbed
- Have blood draws
What is the Condition Being Studied?
Allogeneic (Donor) Stem Cell Transplant
Who Can Participate in this Study?
Adults ages 18-80 who:
- Are scheduled to get an allogeneic stem cell transplant for any type of illness
- Are English-speaking
- Have a caregiver who is willing to participate with them
For more information about who can join this study, please contact the study team at hilary.miller299@duke.edu or 919-668-7238.
Participating Institutions
What is Involved?
We are doing this study to find out if a new treatment strategy called acceptance and commitment therapy (ACT) can help reduce unwanted physical and psychological outcomes after allogeneic stem cell transplant.
Study Details
Full Title
ACT to Reduce Morbidity and Mortality in Hematopoietic Stem Cell Transplant (HCT) Patients
Principal Investigator
Protocol Number
IRB:
PRO00105683
NCT:
NCT04423939
ClinicalTrials.gov
View on ClinicalTrials.gov